Literature DB >> 26311603

Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Pratima Sharma1, Khurram Bari2.   

Abstract

Liver transplantation is the standard of care for patients with decompensated cirrhosis. Liver transplantation recipients have excellent short-term and long-term outcomes including patient and graft survival. Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal disease has risen significantly. Occurrence of Stage 4 chronic kidney disease and end stage renal disease substantially increases the risk of post-transplant deaths. Because majority of late post-transplant mortality is due to nonhepatic post-transplant comorbidities, personalized care directed toward risk factor modification may further improve post-transplant survival.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; ESRD; Liver transplantation; MELD

Mesh:

Year:  2015        PMID: 26311603      PMCID: PMC4556126          DOI: 10.1053/j.ackd.2015.06.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  56 in total

1.  Interferon-free treatment regimens for hepatitis C: are we there yet?

Authors:  Pratima Sharma; Anna S Lok
Journal:  Gastroenterology       Date:  2011-10-25       Impact factor: 22.682

Review 2.  Viral hepatitis and liver transplantation.

Authors:  Pratima Sharma; Anna Lok
Journal:  Semin Liver Dis       Date:  2006-08       Impact factor: 6.115

3.  Impact of MELD-based allocation on end-stage renal disease after liver transplantation.

Authors:  P Sharma; D E Schaubel; M K Guidinger; N P Goodrich; A O Ojo; R M Merion
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

4.  Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis.

Authors:  Faouzi Saliba; Sébastien Dharancy; Richard Lorho; Filoména Conti; Sylvie Radenne; Martine Neau-Cransac; Monika Hurtova; Jean Hardwigsen; Yvon Calmus; Jérome Dumortier
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

5.  Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure.

Authors:  Tse-Ling Fong; Saro Khemichian; Tariq Shah; Ian V Hutchinson; Yong W Cho
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

Review 6.  Simultaneous liver-kidney transplantation summit: current state and future directions.

Authors:  M K Nadim; R S Sung; C L Davis; K A Andreoni; S W Biggins; G M Danovitch; S Feng; J J Friedewald; J C Hong; J A Kellum; W R Kim; J R Lake; L B Melton; E A Pomfret; S Saab; Y S Genyk
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

7.  Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.

Authors:  Ido Laish; Marius Braun; Eytan Mor; Jaqueline Sulkes; Yael Harif; Ziv Ben Ari
Journal:  Liver Transpl       Date:  2011-01       Impact factor: 5.799

8.  A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.

Authors:  L Fischer; J Klempnauer; S Beckebaum; H J Metselaar; P Neuhaus; P Schemmer; U Settmacher; N Heyne; P-A Clavien; F Muehlbacher; I Morard; H Wolters; W Vogel; T Becker; M Sterneck; F Lehner; C Klein; G Kazemier; A Pascher; J Schmidt; F Rauchfuss; A Schnitzbauer; S Nadalin; M Hack; S Ladenburger; H J Schlitt
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

9.  Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.

Authors:  R Ruebner; D Goldberg; P L Abt; R Bahirwani; M Levine; D Sawinski; R D Bloom; P P Reese
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

10.  Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Authors:  P De Simone; F Nevens; L De Carlis; H J Metselaar; S Beckebaum; F Saliba; S Jonas; D Sudan; J Fung; L Fischer; C Duvoux; K D Chavin; B Koneru; M A Huang; W C Chapman; D Foltys; S Witte; H Jiang; J M Hexham; G Junge
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

View more
  8 in total

Review 1.  Management of Post-Liver Transplant Recurrence of Hepatitis C.

Authors:  Justin Taylor; Paula Cox-North; Charles S Landis
Journal:  Drugs       Date:  2016-12       Impact factor: 9.546

2.  Factors predicting kidney delayed graft function among recipients of simultaneous liver-kidney transplantation: A single-center experience.

Authors:  Islam M Korayem; Vatche G Agopian; Keri E Lunsford; Hans A Gritsch; Jeffrey L Veale; Gerald S Lipshutz; Hasan Yersiz; Coney L Serrone; Fady M Kaldas; Douglas G Farmer; Suphamai Bunnapradist; Gabriel M Danovitch; Ronald W Busuttil; Ali Zarrinpar
Journal:  Clin Transplant       Date:  2019-05-07       Impact factor: 2.863

3.  Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant.

Authors:  Yuehong Li; Binbin Li; Wei Wang; Jiaxuan Lv
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

4.  Kidney After Liver Transplantation Matched-pair Analysis: Are Kidneys Allocated to Appropriate Patients to Maximize Their Survival?

Authors:  Michael J Eerhart; José A Reyes; Glen E Leverson; Juan S Danobeitia; Casi L Blanton; Laura J Zitur; Peter J Chlebeck; Luis A Fernandez
Journal:  Transplantation       Date:  2020-04       Impact factor: 5.385

5.  Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.

Authors:  Nwe Ni Than; Claire L Tomlinson; Debashis Haldar; Andrew L King; David Moore; Philip N Newsome
Journal:  Syst Rev       Date:  2016-06-14

6.  Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study.

Authors:  Pratima Sharma; Yihan Sun; Joslyn Neal; Jennifer Erley; James Shen; Sarah Tischer; Christopher J Sonnenday; Jeong M Park
Journal:  Transplant Direct       Date:  2019-08-08

7.  A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter

Authors:  Yücel Yankol; Emily Bugeaud; Tiffany Zens; Michael Rizzari; Nesimi Mecit; Glen E Leverson; David Foley; Joshua D Mezrich; Turan Kanmaz; Oya Münevver Andaçoğlu; Anthony M D'Alessandro; Koray Sadık Acarlı; Münci Kalayoğlu; Luis A Fernandez
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

8.  Intraoperative risk factors of acute kidney injury after liver transplantation.

Authors:  Rachel J Berkowitz; Milo C Engoren; Graciela Mentz; Pratima Sharma; Sathish S Kumar; Ryan Davis; Sachin Kheterpal; Christopher J Sonnenday; Nicholas J Douville
Journal:  Liver Transpl       Date:  2022-04-25       Impact factor: 6.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.